Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients

[Image: see text] Background: Hypercoagulability may contribute to COVID-19 pathogenicity. Evidence comparing clinical outcomes among patients with COVID-19 receiving therapeutic compared to prophylactic dose anticoagulation is limited. We evaluated whether therapeutic anticoagulation (tAC) is assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ionescu, Filip, Nair, Girish B, Petrescu, Ioana, Konde, Anish S, Zimmer, Markie Sue, Anusim, Nwabundo, Jindal, Vishal, Gaikazian, Susanna, Anderson, Joseph, Stender, Michael, Huben, Marianne Terese, Jaiyesimi, Ishmael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
332.Anticoagulation and Antithrombotic Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330269/
http://dx.doi.org/10.1182/blood-2020-134835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330269/
http://dx.doi.org/10.1182/blood-2020-134835

Ejemplares similares